Nachrichten zur Pfizer Aktie

Pfizer sets new prices for its COVID-19 vaccines. The cost? $110 to $130 per dose

The company plans to sell the COVID-19 shot it developed with BioNTech for $110 to $130 per dose once the…

Pfizer Likely To Hike U.S. COVID Vaccine Price

Pfizer Inc. expects to increase the price of its COVID-19 vaccine after the United States governments current purchase program expires,…

Pfizer to Quadruple Price of Covid Vaccine: Report

Pfizer and other pharma companies are under pressure to raise prices to meet revenue targets after government supplies of Covid…

Pfizer will Preis für Impfstoff erhöhen

Das Pharmaunternehmen Pfizer will den Preis für seinen Corona-Impfstoff kräftig erhöhen. Wie Geschäftsführerin Angela Lukin am Donnerstag (Ortszeit) mitteilte, erwägt…

Pfizer mulls hiking US COVID vaccine price ~4 times after government program ends

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pfizer raises price of Covid vaccine in US by four-fold

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pfizer Targets Covid Vaccine Price of at Least $110 a Dose

The drugmaker laid out a potential price as it prepares to sell the shot commercially, perhaps early next year....…

UPDATE 1-Pfizer expects to raise COVID vaccine price to $110-$130 per dose

... (Reuters) - Pfizer Inc expects to raise the price of its COVID-19 vaccine... on shots given so far. Reuters earlier on Thursday…

Pfizer expects to price COVID vaccine at $110-$130 per dose

...NEW YORK (Reuters) - Pfizer Inc expects to charge about $110......…

EU-Kommission lässt Corona-Impfstoff für Babys und gegen Varianten zu

BRÜSSEL (dpa-AFX) - Die EU-Kommission hat die ersten Corona-Impfstoffe für Babys sowie ein an Omikron-Varianten angepasstes Präparat zugelassen. Die Präparate…

Three Stock Lunch: Pfizer, DR Horton and WestRock

Art Hogan, B. Riley Wealth Management chief market strategist, joins 'Power Lunch' to discuss his investing take on three stocks:…

EU-Arzneimittelbehörde macht Weg frei für Corona-Impfstoffe für Babys

AMSTERDAM (dpa-AFX) - Die EU-Arzneimittelbehörde EMA hat den Weg frei gemacht für zwei Corona-Impfstoffe für Babys ab sechs Monaten. Mit…

Pfizer, BioNTech Covid-19 Vaccine Recommended for Children Under 5 Years

Pfizer, BioNTech Covid-19 Vaccine Recommended for Children Under 5 Years...…

Pfizer und BioNTech erhalten positive CHMP-Empfehlung für COMIRNATY® für Kinder im Alter von 6 Monaten bis unter 5 Jahren in der Europäischen Union

NEW YORK und MAINZ, Deutschland, 19. Oktober 2022 — Pfizer Inc. (NYSE: PFE, „Pfizer“) und BioNTech SE (Nasdaq: BNTX, „BioNTech“)…

Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY® in Children 6 Months to less than 5 Years in the European Union

NEW YORK and MAINZ, Germany, October 19, 2022 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced…

FDA authorizes Novavaxs Covid shots as mix-and-match booster to Pfizer or Moderna

Novavaxs Covid shots rely on protein technology used in other vaccines for decades, rather than the messenger RNA used in…

Twitter Is Fine With Pfizer Propaganda, But Comic Books About The US Border Crisis Are Not Allowed

Twitter Is Fine With Pfizer Propaganda, But Comic Books About The US Border Crisis Are Not Allowed …

Fact Check-Aprobación inicial de vacunas contra el COVID-19 no requirió prevención de transmisión del virus; la de Pfizer sí redujo la transmisión de las primeras variantes

...Por Reuters Fact Check 18…

Pfizer (PFE) Gains But Lags Market: What You Should Know

Pfizer (PFE) closed the most recent trading day at $43.65, moving +1.84% from the previous trading session....…

Pfizer: Kursziel gekappt

London (www.aktiencheck.de) - Rating-Update: Carter Gould, Analyst von Barclays, stuft die Aktie des Pharma-Giganten Pfizer Inc. (ISIN: US7170811035, WKN: 852009,…

EU Prosecutor Opens Probe Into COVID Vaccine Purchases

EU Prosecutor Opens Probe Into COVID Vaccine Purchases Two…

Pfizer (PFE) Posts Positive Data on Bivalent BA.4/5 COVID Jab

Pfizer (PFE) and partner BioNTechs Omicron BA.4/BA.5-adapted bivalent COVID vaccine exhibits substantial antibody response above pre-booster levels in adults after…

Pfizer Board Member Scott Gottlieb Secretly Pressed Twitter To Censor Alex Berenson

Pfizer Board Member Scott Gottlieb Secretly Pressed Twitter To Censor Alex Berenson …

The Zacks Analyst Blog Highlights Pfizer, BioNTech, Moderna, Merck and GSK

Pfizer, BioNTech, Moderna, Merck and GSK are included in this Analyst Blog....…

Global Acne Medication Markets Report 2021-2022 & 2030 Featuring Almirall, Bausch, Galderma, Mayne Pharma, GlaxoSmithKline, Mylan, Pfizer, Johnson & Johnson, Sun Pharma, & Teva

DUBLIN, Oct. 14, 2022 /PRNewswire/ -- The "Acne Medication Market by Therapeutic Class, Formulation, Type, Acne Type, and Distribution Channel:…

Lauterbach - Bis zu 400.000 Corona-Infektionen täglich

Berlin (Reuters) - Bundesgesundheitsminister Karl Lauterbach schätzt, dass die Zahl der tatsächlichen täglichen Corona-Infektionen in Deutschland derzeit bis zu 400.000…

Pfizer, BioNTech: Omicron-adapted Vaccine Demonstrates Strong Immune Response on Humans

Pfizer (PFE.US) and BioNTech jointly announced that their COVID-19 vaccine booster, adapted for the BA.4 and the BA.5 subvariants of…

GlaxoSmithKline: Markt verschläft Durchbruch – einsteigen!

GlaxoSmithKline (WKN: A3DMB5) kann US-Konkurrent Pfizer in die Schranken weisen, doch die Aktie kommt nicht vom Fleck. Dabei ist das…

UPDATE 3-Pfizer, BioNTech find updated COVID booster protects against Omicron in trial

... Mishra Oct 13 (Reuters) - Pfizer and its German partner BioNTech said......…

Pharma Stock Roundup: FDA Oks Omicron Jabs for Kids, MRK, MRNA Partner for Cancer Jab

FDA grants emergency approval to Pfizer (PFE) and Modernas (MRNA) Omicron BA.4, BA.5 adapted COVID-19 booster for use in kids.…

GSK, Pfizer Duel Over RSV Vaccine Is Heating Up

U.K. drug maker GSK reported partial results from a respiratory syncytial virus vaccine trial that appear to be at least…

Pfizer says omicron shots substantially boosted antibodies against BA.5 subvariant in early human data

The FDA has authorized Pfizers boosters without direct human data on how they perform against the omicron BA.5 subvariant....…

Biontech: Erste positive Studienergebnisse zu angepasstem Impfstoff

MAINZ (dpa-AFX) - Der an die aktuell vorherrschende Omikron-Untervariante BA.5 angepasste Corona-Impfstoff von Biontech (BioNTech (ADRs)) und Pfizer hat nach…

GSK bereit zum Wettbewerb mit Pfizer im RSV-Impfstoff-Markt

Von Denise Roland LONDON (Dow Jones)--GSK meldet Erfolge bei der Suche nach einem Impfstoff gegen das Respiratorische Synzytialvirus (RSV),…

Pfizer- BioNTech Early Study Data For Omicron BA.4/BA.5-Adapted Bivalent Booster Vaccine, Positive

NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) and BioNTech SE (BNTX) Thursday announced positive early data from the Phase…

Pfizer Says Omicron Booster Lifts Antibodies Against New Variant

Um den gesamten Artikel unter bloomberg.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pfizer says updated booster protects against Omicron subvariants

...(Reuters) - Pfizer Inc and its German partner BioNTech said......…

Pfizer and BioNTech report positive data in trial of omicron-targeting bivalent booster in individuals aged 18 and older

Pfizer Inc. PFE and German partner BioNTech SE BNTX said Thursday early data from a Phase 2/3 clinical trial…

Pfizer says updated booster protects against circulating COVID variants

...Oct 13 (Reuters) - Pfizer Inc and its German partner BioNTech said......…

Pfizer and BioNTech Announce Positive Early Data From Clinical Trial of Omicron BA.4/BA.5-Adapted Bivalent Booster in Individuals 18 Years and Older

NEW YORK and MAINZ, GERMANY, October 13, 2022 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced…

Pfizer und BioNTech geben frühe positive Daten aus klinischer Studie mit an Omikron BA.4/BA.5 angepasstem bivalenten Auffrischungsimpfstoff bei Personen ab 18 Jahren bekannt

NEW YORK und MAINZ, Deutschland, 13. Oktober 2022 — Pfizer Inc. (NYSE: PFE, „Pfizer“) und BioNTech SE (Nasdaq: BNTX, „BioNTech“)…

FDA Allows Covid-19 Booster Shots for Children

The regulator granted emergency-use authorization for children as young as five to receive the Covid-19 vaccines. Stock in Pfizer and…

Pfizer: FDA Grants Emergency Use Of Omicron Bivalent COVID-19 Vaccine Booster In Children

NEW YORK CITY (dpa-AFX) - The U.S. Food and Drug Administration granted Emergency Use Authorization for a 10-micro gram booster…

Pfizer, BioNTech stocks surge after FDA grants emergency use of BA.4, BA.5 adapted booster shots in children

Shares of Pfizer Inc. PFE climbed 2.2% and BioNTech SE BNTX hiked up 5.5% in morning trading Wednesday, after the…

Pfizer, Moderna COVID boosters authorized for children as young as 5 years old

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Coronavirus (COVID-19) Update: FDA Authorizes Moderna and Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as a Booster Dose in Younger Age Groups

SILVER SPRING, Md., Oct. 12, 2022 /PRNewswire/ -- Today, the U.S. Food and Drug Administration amended the emergency use authorizations…

dpa-AFX ProFeed